<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04801407</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-03-06</org_study_id>
    <nct_id>NCT04801407</nct_id>
  </id_info>
  <brief_title>Comparative Study inTreatment of Trigeminal Neuralgia</brief_title>
  <official_title>Comparative Study Between Microvascular Decompression and Percutaneous Radiofrequency Rhizotomy for Treatment of Trigeminal Neuralgia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the results of percutaneous radiofrequency rhizotomy and the&#xD;
      effectiveness of microvascular decompression for the treatment of trigeminal neuralgia and&#xD;
      Comparing between them according the different outcome parameters.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is prospective case -series hospital based study, will be conducted on 40 patients with&#xD;
      trigeminal neuralgia treated either by percutaneous radiofrequency trigeminal rhizotomy or&#xD;
      microvascular decompression at Sohag University Hospitals, between march 2021 and June 2022&#xD;
      and we will divide the the patients into two groups ,one group will be treated with&#xD;
      percutaneous radiofrequency trigeminal rhizotomy and the other group will be treated with&#xD;
      microvascular decompression and we will asses the results with the Barrow Neurological&#xD;
      Institute Pain Intensity Score .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective case -series hospital based study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Barrow Neurological Institute Pain Intensity Score</measure>
    <time_frame>3 months</time_frame>
    <description>I (no pain, no medication), II (occasional pain, not requiring medication), III (some pain, controlled with medication), IV (some pain, not controlled with medication) V (severe pain, no pain relief with medication).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Trigeminal Neuralgia</condition>
  <arm_group>
    <arm_group_label>radiofrequency group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>it is the group that will be treated with Percutaneous Radiofrequency Rhizotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Microvascular decompression group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>it is the group that will be treated with Microvascular decompression</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>percutaneous radiofrequency trigeminal rhizotomy</intervention_name>
    <description>percutaneous radiofrequency trigeminal rhizotomy is a perctaneous procedure that ablate the sensory part of the nerve and</description>
    <arm_group_label>radiofrequency group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microvascular decompression of the trigeminal nerve</intervention_name>
    <description>Microvascular decompression is a procedure that decompress the nerve from vascular conflict</description>
    <arm_group_label>Microvascular decompression group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Failed medical treatment more than 6 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Coagulation disorder or hemorrhagic disease;&#xD;
&#xD;
          -  Mental illness and inability to cooperate;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mohamed Abdelsamee Ahmed</name>
      <address>
        <city>Sohag</city>
        <state>Sohag City</state>
        <zip>82514</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>roshdy elkhyat</last_name>
      <phone>+201223486390</phone>
      <email>mohamedneurosurgery33@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>abdin khair-allah</last_name>
      <phone>+201020196831</phone>
      <email>abdin_mail@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 11, 2021</study_first_submitted>
  <study_first_submitted_qc>March 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2021</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>mohmed abdelsamee ahmed</investigator_full_name>
    <investigator_title>assistant lecturer neurosurgery department</investigator_title>
  </responsible_party>
  <keyword>trigeminal neuralgia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trigeminal Neuralgia</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

